Archives
-
L1023 Anti-Cancer Compound Library Workflow
2026-08-19
Use the L1023 Anti-Cancer Compound Library to connect phenotypic screening with pathway-level follow-up in resistant cancer models. Its pre-dissolved format supports efficient comparison of kinase inhibitors, apoptosis modulators, and compounds linked to MCL1, BRAF, and mTOR biology.
-
PTGER4–HDAC Signaling in Rectal Epithelial Cells
2026-08-18
Anbazhagan et al. identify a stromal-to-epithelial signaling mechanism in which MSC-derived PGE2 activates PTGER4 and changes class IIa HDAC phosphorylation, increasing SPINK4 mRNA in rectal organoids. The work links inflammatory lipid signaling to epithelial transcriptional regulation and provides a patient-derived experimental framework for studying mucosal repair and Crohn’s disease biology.
-
Ridaforolimus Workflows for mTOR Cancer Research
2026-08-18
Turn nanomolar mTOR inhibition into practical workflows for proliferation, signaling, VEGF, apoptosis, and senescence-model experiments. Ridaforolimus (Deforolimus) is especially useful when pathway engagement must be connected to functional phenotypes rather than inferred from viability alone.
-
CUDC-907: Practical Dual PI3K/HDAC Guide
2026-08-17
CUDC-907 provides a research tool for simultaneous investigation of PI3K and HDAC activity in controlled cancer-cell assays, including pathway, cell-cycle, and apoptosis workflows. It is intended for scientific research only and should not be used for diagnosis, treatment, or clinical conclusions.
-
AO/PI Double Staining Kit for Melanoma Cell Fate
2026-08-17
Turn one fluorescence readout into a practical map of viable, apoptotic, and necrotic melanoma cells. This workflow shows how to use AO/PI staining alongside caspase, DNA-fragmentation, and morphology data to distinguish treatment response from nonspecific cell damage.
-
GS967 and the Late Sodium Current in Aging Hearts
2026-08-16
A mechanistic and translational perspective on how GS967 can help researchers connect Nav1.5 regulation, late sodium influx, repolarization delay, diastolic dysfunction, and arrhythmia susceptibility in aging and disease-relevant cardiac models.
-
T7 RNA Polymerase for mRNA Workflow Design
2026-08-15
Build reproducible RNA workflows around promoter-selective transcription, from linearized plasmid templates to research-scale mRNA production. This guide connects practical IVT setup and troubleshooting with the antigen-design findings of a varicella-zoster virus mRNA vaccine study.
-
Norepinephrine Bitartrate: Formulation-Smart Research
2026-08-14
Norepinephrine bitartrate is a powerful tool for adrenergic and cardiovascular research, but salt-versus-base reporting can determine whether results are genuinely comparable. This guide connects receptor pharmacology with formulation-aware assay design, dose interpretation, and reproducibility.
-
EZ Cap™ Cas9 mRNA (m1Ψ) Workflow Guide
2026-08-14
Build more controllable CRISPR experiments with a Cap1-capped, m1Ψ-modified Cas9 transcript designed for efficient translation and reduced RNA-sensing concerns. This guide connects practical delivery and troubleshooting decisions with evidence that regulating Cas9 mRNA nuclear export can improve editing precision.
-
DDX21 Promotes Colorectal Cancer Metastasis
2026-08-13
This 2025 study identifies a DDX21–SIRT7–NAT10 regulatory axis that links chromatin regulation to ac4C-dependent mRNA stability in colorectal cancer. The findings explain how DDX21 supports both metastatic behavior and angiogenesis through stabilization of ATAD2, SOX4, and SNX5 transcripts.
-
Cell Senescence β-Galactosidase Staining Kit Guide
2026-08-13
Learn how Cell Senescence β-Galactosidase Staining Kit K2185 can improve senescent cell detection across culture and frozen-tissue workflows. This scenario-based guide covers assay design, protocol control, interpretation, compatibility, and practical vendor selection.
-
EZ Cap™ Cas9 mRNA (m1Ψ) Workflow Guide
2026-08-12
Build a controlled CRISPR-Cas9 mRNA workflow around Cap1 capping, m1Ψ modification, poly(A)-supported translation, and careful dose timing. This guide also translates evidence on Cas9 mRNA nuclear export into practical assays for improving editing specificity in mammalian cells.
-
CXCR4 Theranostics in Lymphoma: Evidence and Limits
2026-08-12
This 2026 review presents CXCR4 as a bridge between molecular imaging and targeted treatment in lymphoma, linking receptor biology with PET, SPECT, radioligand therapy, inhibitors, and antibody-based strategies. Its practical value lies in showing how CXCR4 expression may support disease characterization and treatment selection while also emphasizing physiological uptake, CXCR7 compensation, and the need for better patient stratification.
-
Loop Extrusion Rate Tunes Genome Folding
2026-08-11
The reference preprint identifies cohesin loop-extrusion rate as a tunable parameter controlled by NIPBL and PDS5 dosage. Its findings suggest that altered extrusion dynamics can be buffered to preserve chromosome structure and transcription, but that this buffering also creates vulnerability to dosage changes relevant to cohesinopathies.
-
GS-441524 Prodrug Assay Workflow Guide
2026-08-11
Build more informative antiviral and pharmacokinetic assays by tracking both GS-441524 and its prodrug-derived metabolite across biological matrices. This practical guide combines material handling, LC–MS/MS workflow design, conversion controls, and troubleshooting for research teams studying SARS-CoV-2-related mechanisms.